Nitromed has been in trouble for several years now. They're a
perfect example of a dog that caught a car: a company that was demolished by actually getting its drug on the market. No one wanted to pay for it, though, and after
all that expense the company was left worse off than before.
Their remnants, though, are still listed on the NASDAQ, and that's more than a lot of more promising companies can say. One of those is Archemix, a company that I see every day on my way to work in...
Share it
Read the Full Story at In the Pipeline
embed
